<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>The Raw Logs — #biotech</title><link>https://therawlogs.com/tag/biotech</link><description>Top takes tagged #biotech.</description><language>en</language><lastBuildDate>Tue, 08 Sep 2026 16:06:53 GMT</lastBuildDate>    <item><title>#biotech — Clinical Multimodal Model Detects Colon Cancer in Routine Non‑Contrast CT Scans</title><link>https://therawlogs.com/take/18-4</link><guid>https://therawlogs.com/take/18-4</guid><pubDate>Sat, 05 Sep 2026 18:24:58 GMT</pubDate><description><![CDATA[Clinical Multimodal Model Detects Colon Cancer in Routine Non‑Contrast CT Scans: An AI model identified colon cancer on routine non‑contrast CT scans with 88% sensitivity in 18,000 patients. Radiologists seldom examine colon tissue during trauma scans. Integrating automated screening into existing pipelines detects tumors years earlier. [#biotech]]]></description></item>    <item><title>#biotech — Allen Institute, UW, and Fred Hutch Launch a $95M Open Biology AI Initiative</title><link>https://therawlogs.com/take/16-3</link><guid>https://therawlogs.com/take/16-3</guid><pubDate>Thu, 03 Sep 2026 16:50:11 GMT</pubDate><description><![CDATA[Allen Institute, UW, and Fred Hutch Launch a $95M Open Biology AI Initiative: The Allen Institute, UW, and Fred Hutch launched a $95M open-science initiative to train AI in cell biology. Closed commercial biology APIs lock drug designs behind paywalls. Open biological models let research teams build and test molecular medicines without licensing fees. [#biotech]]]></description></item>    <item><title>#biotech — Insilico Medicine earns nine‑figure revenue from AI‑designed drugs in clinical trials.</title><link>https://therawlogs.com/take/10-5</link><guid>https://therawlogs.com/take/10-5</guid><pubDate>Wed, 26 Aug 2026 16:15:43 GMT</pubDate><description><![CDATA[Insilico Medicine earns nine‑figure revenue from AI‑designed drugs in clinical trials.: Insilico Medicine reached nine-figure revenue from AI-designed drug molecules in human clinical trials. Traditional drug discovery takes five years and $500M of lab screening. Generative molecular models produce viable clinical candidates in under 12 months at 80% lower cost. [#biotech]]]></description></item></channel></rss>